Stainless steel bioreactors

Facilitates Fermentation and Cultivation for Biomanufacturing

The Biostat® Cplus and Biostat® D-DCU from Sartorius are stainless steel bioreactors designed specifically for biopharmaceutical manufacturing. These systems stand out due to their integration of advanced process analytical technologies (BioPAT®) for precision control and regulation during fermentation and cultivation processes. Ideal for producing monoclonal antibodies, mRNA vaccines, and other biologics, these bioreactors offer scalable solutions from pilot to small production scales. Each unit supports seamless PLC-based automation, ensuring consistent product quality and efficiency while reducing manual intervention.

With capabilities extending from 5L to 2,000L, they facilitate diverse operations such as mixing, separation, and purification, essential for maintaining high purity levels in bioproducts like insulin and CAR-T cell therapies. Available in corrosion-resistant stainless steel, these bioreactors are designed for durability and compliance with GMP and FDA standards, ensuring suitability for regulated environments. Their design includes features for easy cleaning and maintenance, including a CIP system, making them an optimal choice for hassle-free operation and long-term reliability in demanding bioprocess settings. Customization options further enhance the adaptability of Biostat® systems to specific application needs, backed by Sartorius’s expert engineering support.